Christine Kampf

Christine Kampf currently serves as Vice President of Regulatory Affairs at Palvella Therapeutics, a position held since November 2024. Previously, Kampf held the role of Executive Director for Global Regulatory Affairs at RemeGen Biosciences for a brief period in late 2024. With extensive experience in regulatory affairs across multiple organizations, Kampf has served as Executive Director and Senior Director of Regulatory Affairs at Marinus Pharma, Senior Director, Head of Regulatory Affairs at Bellus Health, and Director of Regulatory Affairs at Braeburn. Kampf's career began at Cephalon and progressed through various positions at Teva Pharmaceuticals, culminating in management roles. Educational credentials include a Master of Science in Biology from Drexel University and a Bachelor of Arts in Anthropology, Microbiology, and Immunology from the University of Miami.